Academics and leading medical specialists in Birmingham are to work together on a groundbreaking clinical trials project.
University of Birmingham and University Hospitals Birmingham NHS Foundation Trust have signed an agreement to become Birmingham Health Partners.
It will mean patients at Queen Elizabeth Hospital, in Edgbaston, get more opportunities to try new treatments being developed by world-leading clinical trials teams.
The agreement will create a new clinical academic structure and fuel projects in key research areas including cancer, immunology and infection; experimental medicine and chronic disease.
Professor Charlie Craddock, transitional director of Birmingham Health Partners, said: “This visionary partnership will not only allow us to deliver world-class therapies to patients in the West Midlands but will act as a magnet for inward investment by pharmaceutical companies and a catalyst for economic regeneration.”
The move aims to strengthen the global reputations of both institutions, which have already collaborated on the first Cancer Research UK Centre, based in Birmingham and a major centre for clinical trials, the Wellcome Trust Clinical Research Facility and the Institute for Biomedical Research.